KRRO Korro Bio, Inc.
Company Analysis
Latest News
🟢 Korro Bio is trading 5% up today; catalyst remains unconfirmed
Korro Bio is trading 5.05% up now at $14.78 on September 16, 2026, with no confirmed catalyst identified. - The latest identified company news was a September...
🔴 Korro Bio falls 5.4% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Korro Bio is trading 6.37% up today; no clear catalyst identified
Korro Bio is trading at $14.69, up 6.37%, with no clear catalyst identified. - No new company-specific announcement was identified for September 14, 2026. -...
🟢 Korro Bio is trading 5.5% up today as major U.S. indexes gain more than 1%
Korro Bio is trading 5.5% up at $13.78 as broad U.S. equity markets strengthened on September 11, 2026. - The S&P 500, Nasdaq Composite, and Dow Jones...
🟢 Korro Bio is trading 10.44% up today with no confirmed company-specific catalyst
Korro Bio is trading 10.44% up at $13.52, with no confirmed company-specific catalyst identified for September 8, 2026. - An August 27 corporate update...
🟢 Korro Bio is trading 5.56% up today despite no confirmed company-specific catalyst
Korro Bio is trading 5.56% up at $12.92, with the catalyst still unconfirmed. - No company-specific announcement dated September 8, 2026, clearly explains the...
🟢 Korro Bio is trading 5% up today
Korro Bio is trading 5.38% up at $12.24, reversing part of its recent seven-session decline. - No major company-specific announcement, filing, earnings...
🔴 Korro Bio is trading 5% down today
Korro Bio is trading 5.18% down now at $11.35, extending a seven-session decline from $13.73 on August 25, 2026. - No major company-specific announcement,...
🔴 Korro Bio is trading 6.97% down in pre-market as global yields pressure biotech shares
Korro Bio is trading $11.62 (-6.97%) in pre-market as rising global yields pressure risk-sensitive biotechnology shares. - No new company-specific...
🟢 Korro Bio rises 5.4% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🔴 Korro Bio is trading 6.25% down in after-hours trading after biotech ETFs reversed sharply
Korro Bio is trading 6.25% down at $12.15 after a broad biotech-sector pullback. - It fell 7.10% during the August 20, 2026 regular session; no...
🔴 Korro Bio falls 5.3% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
Korro Bio Submits Application to Initiate Phase 1/2 Clinical Trial for KRRO-121
Korro Bio, Inc. announced it has submitted an application to the Australian Alfred Health Human Ethics Committee to begin a first-in-human Phase 1/2 clinical...
🟢 Korro Bio rises 5.3% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
Korro Bio, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
For the second quarter of 2026, analysts expect Korro Bio to report a consensus revenue of $0.51 million and an EPS loss of $1.54, with the stock currently...
🟢 Korro Bio is trading 6.4% up today after narrower net loss
Korro Bio is trading 6.4% up now at $12.89 after August 6, 2026 earnings highlighted a narrower $18.9 million net loss. - Cash totaled $137.9 million, with...
Korro Bio narrows second quarter 2026 net loss to $18.9M and extends cash runway into the second half of 2028.
Korro Bio reported a net loss of $18.9 million, or ($1.07) per share, for the second quarter of 2026, with no collaboration revenue recognized. The company...
🟢 Korro Bio is trading 5.6% up today amid a broad biotech rally and risk-on market sentiment
Korro Bio is trading at $11.34 (+5.59%) with no company-specific news, moving higher alongside a broad risk-on session and strength in the biotech sector. •...
🔴 Korro Bio is trading 5.3% down today on normal volatility
Korro Bio is trading 5.3% down at $10.07 today on normal volatility, as there are no fresh company-specific catalysts or news releases to drive the price...
🔴 Korro Bio is trading 8.1% down today amid broad market weakness and after-hours volatility
Korro Bio is trading at $9.25 (8.1% down) in after-hours trading, extending a downward trend from recent highs amid broad market weakness. • The stock...